Covers recent developments in cardiac nuclear medicine that enable specialists to collect information which is unavailable by imaging techniques such as echocardiology or coronary angiography. The book summarizes principles and applications of new radiotracers, focusing on both recently approved new radiopharmaceuricals and those likely to be approved.
Part I 99mTc-labeled perfusion imaging agents: 99mTc-Sestamibi; 99mTc-Tetrofosmin; 99mTc-N-NOEt. Part II Metabolic imaging agents: IPPA and other 123I straight-chain fatty acids; BMIPP and other 123I branched fatty acids. Part III Infarct avid imaging agents: 111Indium-antimyosin; 9mTc-antimyosin, 9mTc-glucarate. Part IV Positron emission tomography agents: PET perfusion tRacers; F-18 FDG; other PET tracers. Part V Miscellaneous: 123I MIBG; hypoxia.